Subscribe to RSS
DOI: 10.1055/s-0030-1262396
© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG
Das Restless-legs-Syndrom (RLS) – Erfahrungsbericht mit einem Vitex agnus-castus (VAC)-Extrakt
Publication History
Publication Date:
08 November 2010 (online)

Zusammenfassung
Ethanolische Extrakte der Früchte von Vitex agnus-castus (VAC) wirken als gemischter Dopamin-D2/D3-Rezeptoragonist. Das RLS wird therapiert mit Dopaminagonisten. Ein erster Therapieversuch mit einem standardisierten VAC-Extrakt, d.h. mit einem pflanzlichen Dopaminagonisten, an einer kleinen Patientenzahl (n = 12) ergab vielversprechende Ergebnisse, die durch systematische Untersuchungen zu verifizieren sind.
Summary
The restless legs syndrome. First experiences with an extract from Vitex agnus-castus Ethanolic extracts from the fruits of Vitex agnus-castus (VAC) act as a mixed D2/D3 receptor agonist. Dopamine agonists are first line therapy for restless legs syndrome (RLS). In a small group of patients (n = 12) suffering from RLS a standardized VAC extract was tested as a dopamine agonist derived from plants for the first time. The outcome is promising and further clinical trials should be stimulated.
Schlüsselwörter
Vitex agnus-castus L. - gemischter Dopaminagonist - Restless-legs-Syndrom - Erfahrungsbericht
Key words
Vitex agnus-castus L. - mixed dopamine agonist - restless legs syndrome - clinical experience - off-label use
Literatur
- r1 Baker WL. White CM. Coleman CI. Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med. 2008; 6 253-262
- r2 Barriere G. Cazalets JR. Bioulac B. , et al. The restless legs syndrome. Prog Neurobiol. 2005; 77 139-165
- r3 Brattström A. Meier B. Dimpfel W. CNS dopamine agonist action of the Vitex agnuscastus extract Ze 440 in freely moving, chronically instrumented animals. Z Phytother. 2008; 29 ((Suppl. 1)) S5-S6
- r4 Brattström A. Use of Vitex agnus castus extracts for preparing a medicament. 2009 Patent Internal Application No.: PTC/EP2008/007051
- r5 Collins GT. Witkin JM. Newman AH. , et al. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behaviour. J Pharmacol Exp Ther. 2005; 314 310-319
- r6 Collins GT. Newman AH. Grundt P. , et al. Yawning and hyperthermia in rats: effect of dopamine D3 and D2 agonists and antagonists. Psychopharmacol. 2007; 193 159-170
- r7 Daniele C. Coon JT. Pittler MH. Ernst E. Vitex agnus castus. A systematic review of adverse events. Drug Safety. 2005; 28 319-332
- r8 Hoberg E. Orjala J. Meier B. Sticher O. Diterpenoids from the fruits of Vitex agnus-castus. . Phytochemistry. 1999; 52 1555-1558
- r9 Hoberg E. Meier B. Sticher O. Quantitative high performance liquid chromatographic analysis of casticin in the fruits of Vitex agnus-castus. . Pharmaceutical Biol. 2001; 39 57-61
- r10 Jarry H. Leonhardt S. Wuttke W. , et al. Agnus castus als dopaminerges Wirkprinzip in Mastodynon N. Z Phytother. 1991; 12 77-82
- r11 Jarry H. Spengler B. Wuttke W. Christoffel V. In vitro assays for bioactivity-guided isolation of endocrine active compounds in Vitex agnus-castus. . Maturitas. 2006; 55 S26-S36
- r12 Joyce JN. Millan MJ. Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Curr Opin Pharmacol. 2007; 7 100-105
- r13 van Kampen JM. Robertson HA. A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra. Neuroscience. 2005; 136 381-386
- r14 van Kampen JM. Eckman CB. Dopamine D3 receptor agonist delivery to a model of Parkinson's diseases restores the nigrostriatal pathway and improves locomotor behaviour. J Neuroscience. 2006; 26 7272-7280
- r15 Kushida C. Martin M. Nikam P. , et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res. 2007; 16 617-624
- r16 Medcalf P. Bhatia KP. Restless legs syndrome. BMJ. 2006; 333 457-458
- r17 Meier B. Berger D. Hoberg E. , et al. Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine. 2000; 7 373-381
- r18 Millan MJ. Seguin L. Gobert A. , et al. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats. Psychopharmacology. 2004; 174 341-357
- r19 Paulus W. Dowling P. Rijsman R. , et al. Pathophysiological concepts of restless legs syndrome. Mov Disord. 2007; 22 1451-1456
- r20 Rizzo V. Arico I. Mastroeni C. , et al. Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome. Mov Disord. 2009; 24 710-705
- r21 Satija P. Ondo W. Restless legs syndrome: Pathopysiology, diagnosis and treatment. CNS Drugs. 2008; 22 497-518
- r22 Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. 2001; 322 134-137
-
r23 Simmen U. Löchner C. Jordan M. et al. Multiple batch affinity of a chaste tree (Vitex agnus castus L.) extract (Ze 440) to dopamine D3 receptors. 51st Annual Congress Medicinal Plant Research, 31.8.–4.9.2003 Kiel, Germany. Book of Abstracts: p 199
- r24 Diener HC. Putzki N. Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 4. Aufl. Stuttgart; Thieme 2008: 56-67
Prof. Dr. Axel Brattström
Alexander Puschkin Str. 50
39108 Magdeburg
Email: Axel.Brattstroem@t-online.de
Priv.-Doz. Dr. Wolf-Dietrich Kaiser
Nordhäuser Str. 1
99089 Erfurt
Email: info@doktor-kaiser.de
Online